Deborah Cromer1, Andrew J Grimm, Timothy E Schlub, Johnson Mak, Miles P Davenport. 1. aComplex Systems in Biology Group, Centre for Vascular Research, University of New South Wales, KensingtonbInfection Analytics Program, Kirby Institute, University of New South WalescSchool of Public Health, Sydney University, Camperdown, New South WalesdSchool of Medicine, Faculty of Health, Deakin UniversityeCSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Abstract
BACKGROUND: HIV recombination has been estimated in vitro using a variety of approaches, and shows a high rate of template switching per reverse transcription event. In-vivo studies of recombination generally measure the accumulation of recombinant strains over time, and thus do not directly estimate a comparable template switching rate. METHOD: To examine whether the estimated in-vitro template switching rate is representative of the rate that occurs during HIV infection in vivo, we adopted a novel approach, analysing single genome sequences from early founder viruses to study the in-vivo template switching rate in the env region of HIV. RESULTS: We estimated the in-vivo per cycle template switching rate to be between 0.5 and 1.5/1000 nt, or approximately 5-14 recombination events over the length of the HIV genome. CONCLUSION: The in-vivo estimated template switching rate is close to the in-vitro estimated rate found in primary T lymphocytes but not macrophages, which is consistent with the majority of HIV infection occurring in T lymphocytes.
BACKGROUND: HIV recombination has been estimated in vitro using a variety of approaches, and shows a high rate of template switching per reverse transcription event. In-vivo studies of recombination generally measure the accumulation of recombinant strains over time, and thus do not directly estimate a comparable template switching rate. METHOD: To examine whether the estimated in-vitro template switching rate is representative of the rate that occurs during HIV infection in vivo, we adopted a novel approach, analysing single genome sequences from early founder viruses to study the in-vivo template switching rate in the env region of HIV. RESULTS: We estimated the in-vivo per cycle template switching rate to be between 0.5 and 1.5/1000 nt, or approximately 5-14 recombination events over the length of the HIV genome. CONCLUSION: The in-vivo estimated template switching rate is close to the in-vitro estimated rate found in primary T lymphocytes but not macrophages, which is consistent with the majority of HIV infection occurring in T lymphocytes.
Authors: Taina T Immonen; Celine Camus; Carolyn Reid; Christine M Fennessey; Gregory Q Del Prete; Miles P Davenport; Jeffrey D Lifson; Brandon F Keele Journal: Proc Natl Acad Sci U S A Date: 2019-12-16 Impact factor: 11.205
Authors: Abayomi S Olabode; Garway T Ng; Kaitlyn E Wade; Mikhail Salnikov; Heather E Grant; David W Dick; Art F Y Poon Journal: Proc Natl Acad Sci U S A Date: 2022-05-02 Impact factor: 12.779
Authors: Hongshuo Song; Elena E Giorgi; Vitaly V Ganusov; Fangping Cai; Gayathri Athreya; Hyejin Yoon; Oana Carja; Bhavna Hora; Peter Hraber; Ethan Romero-Severson; Chunlai Jiang; Xiaojun Li; Shuyi Wang; Hui Li; Jesus F Salazar-Gonzalez; Maria G Salazar; Nilu Goonetilleke; Brandon F Keele; David C Montefiori; Myron S Cohen; George M Shaw; Beatrice H Hahn; Andrew J McMichael; Barton F Haynes; Bette Korber; Tanmoy Bhattacharya; Feng Gao Journal: Nat Commun Date: 2018-05-15 Impact factor: 14.919
Authors: Jillian S Y Lau; Deborah Cromer; Mykola Pinkevych; Sharon R Lewin; Thomas A Rasmussen; James H McMahon; Miles P Davenport Journal: J Infect Dis Date: 2022-08-24 Impact factor: 7.759